BAXTER'S $448 MIL. SALE OF DIAGNOSTICS MANUFACTURING BUSINESSES
This article was originally published in The Gray Sheet
Executive Summary
BAXTER'S $448 MIL. SALE OF DIAGNOSTICS MANUFACTURING BUSINESSES will help the company reduce its debt-to-capital ratio to about 40% by the end of 1994, according to Baxter. The company announced Oct. 3 a definitive agreement for the sale of its manufacturing operations to Bain Capital, expected to close before the end of the year. Baxter is retaining exclusive U.S. distribution fights to its diagnostics products businesses for five years.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.